UC to Test New Targeted Treatment for Prostate Cancer

(PhysOrg.com) -- The American Cancer Society estimates one man in six will get prostate cancer during his lifetime, making it the second leading cause of cancer death in men. With a new partnership with Areva Med, University of Cincinnati researchers will investigate the use of a new drug in stopping the growth of prostate cancer tumors.

Read the whole article on Physorg

More from Physorg